![]() |
|
|
Molecular Pharmacology, Vol 5, 593-604, Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics
1 Laboratory of Chemical Pharmacology, National Heart Institute, National Institutes
of Health, Bethesda, Maryland 20014
When ouabain and labeled serotonin (14C-5-HT) or norepinephrine (3H-NE) are simultaneously introduced into a suspension of isolated nerve endings (synaptosomes) in Krebsbicarbonate solution, the initial accumulation of 3H-NE by the synaptosomes proceeds for a few minutes, then abruptly stops. When ouabain is first incubated with synaptosomes in the absence of substrate, the initial accumulation of 14C-5-HT subsequently added is blocked. Thus, a lapse of time is required for the inhibitory effect of ouabain to develop. Moreover, Na+ must also be present with the ouabain. In contrast, ouabain inhibits (Na+ + K+)-ATPase activity immediately. It appears, therefore, that ouabain blocks the accumulation of amine by an indirect process resulting from the inhibition of (Na+ + K+)-ATPase. The indirect process requires Na+ and is probably the increase in the intracellular Na+ concentration which occurs in the presence of ouabain.
Submitted on May 26, 1969